Effects of disodium etidronate in murine tumor models
- 1 May 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (5) , 685-693
- https://doi.org/10.1016/0277-5379(84)90017-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983
- Parenteral diphosphonates for treating malignant hypercalcemiaCancer, 1981
- The Multiple Causes of Hypercalcemia in Malignant DiseaseNew England Journal of Medicine, 1980
- The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysisBritish Journal of Surgery, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- DiphosphonatesCalcified Tissue International, 1979
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Selective antimetastatic treatment—current status and future prospectsCancer Treatment Reviews, 1974
- Lymph‐node metastases after intratibial transplantation of tumorsInternational Journal of Cancer, 1968